Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma

被引：8
|
作者：
Kato, Takashi [1 ]
Oshikiri, Taro [1 ]
Goto, Hironobu [1 ]
Sawada, Ryuichiro [1 ]
Harada, Hitoshi [1 ]
Urakawa, Naoki [1 ]
Hasegawa, Hiroshi [1 ]
Kanaji, Shingo [1 ]
Yamashita, Kimihiro [1 ]
Matsuda, Takeru [2 ]
Kakeji, Yoshihiro [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Surg, Div Minimally Invas Surg, Kobe, Hyogo, Japan
来源：
ANTICANCER RESEARCH | 2022年 / 42卷 / 05期
关键词：
Biomarker; esophageal squamous cell carcinoma; platelet-to-lymphocyte ratio; RECURRENT LARYNGEAL NERVE; CHARACTERISTIC ROC CURVE; LAPAROSCOPIC SURGERY; CANCER; LYMPHADENECTOMY; INFLAMMATION; LEUKOCYTE; SURVIVAL; OUTCOMES;
D O I：
10.21873/anticanres.15757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background/Aim: Esophageal squamous cell carcinoma (ESCC) is a deadly malignant disease. This study examined whether the platelet-to-lymphocyte ratio (PLR) can be used as a biomarker to evaluate prognosis in patients with advanced ESCC following neoadjuvant chemotherapy (NAC) and undergoing minimally invasive esophagectomy (MIE). Patients and Methods: We examined 174 patients between January 2010 and December 2015 at the Kobe University. Of these, 121 were treated with NAC. The PLR cutoff was determined through receiver-operating characteristic curve analysis. Univariate and multivariate analyses were conducted to identify prognostic factors for overall survival (OS). Results: The PLR cutoff for OS in 121 patients was 169.6. Patients with PLR 169.6 (61.1%, p=0.001). Multivariate analysis revealed that a PLR of 169.6 was an independent factor for poor prognosis. Conclusion: PLR is an independent prognostic factor for patients with ESCC after NAC and MIE.
引用
收藏
页码：2775 / 2782
页数：8
相关论文
共 50 条
  • [21] Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients
    Chen, Yibiao
    Sun, Jianda
    Hu, Dan
    Zhang, Jian
    Xu, Yuyun
    Feng, Huiting
    Chen, Zhijie
    Luo, Yi
    Lou, Yunlong
    Wu, Heming
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8767 - 8779
  • [22] Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation
    Chen, Yi
    Yang, Yi
    Zhang, Xin-yuan
    Fan, Qing-sheng
    Li, Xiao
    Xin, Yu-Jing
    Cao, Xiao-Jing
    Wang, Ya-Nan
    Zhou, Xiang
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (10) : 1551 - 1560
  • [23] Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma
    Duan, Hao
    Zhang, Xu
    Wang, Fei-Xiang
    Cai, Mu-Yan
    Ma, Guo-Wei
    Yang, Hong
    Fu, Jian-Hua
    Tan, Zi-Hui
    Meng, Yu-Qi
    Fu, Xia-Yu
    Ma, Qi-Long
    Lin, Peng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (18) : 5591 - 5597
  • [24] Preoperative platelet-lymphocyte ratio predicts recurrence of laryngeal squamous cell carcinoma
    Chen, Huijun
    Song, Shenghua
    Zhang, Liqing
    Dong, Weida
    Chen, Xi
    Zhou, Han
    FUTURE ONCOLOGY, 2020, 16 (06) : 209 - 217
  • [25] Assessment of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Prognosis of Oral Squamous Cell Carcinoma
    Tazeen, Sanah
    Prasad, Kavitha
    Harish, Krishnamachar
    Sagar, Parimala
    Kapali, Aravind S.
    Chandramouli, Satish
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2020, 78 (06) : 949 - 960
  • [26] Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma
    Feng, Ji-Feng
    Huang, Ying
    Liu, Jin-Shi
    ONCOTARGETS AND THERAPY, 2013, 6 : 1605 - 1612
  • [27] Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
    Wang, Wenjian
    He, Xiaotian
    Zheng, Zehua
    Ma, Xiaofan
    Hu, Xueting
    Wu, Duoguang
    Wang, Minghui
    MOLECULAR CANCER, 2017, 16
  • [28] Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy
    Lee, Dong Soo
    Kim, Chang Wook
    Kim, Hee Yeon
    Ku, Young-Mi
    Won, Yoo Dong
    Lee, Su-Lim
    Sun, Der Sheng
    CANCERS, 2023, 15 (07)
  • [29] Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study
    Ertekin, Sumeyre Seda
    Mangas, Cristina
    Riquelme-Mc Loughlin, Constanza
    Carrera, Cristina
    Malvehy, Josep
    Puig, Susana
    Podlipnik, Sebastian
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [30] The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients
    Jiang, Rou
    Zou, Xiong
    Hu, Wen
    Fan, Yu-Ying
    Yan, Yue
    Zhang, Meng-Xia
    You, Rui
    Sun, Rui
    Luo, Dong-Hua
    Chen, Qiu-Yan
    Huang, Pei-Yu
    Hua, Yi-Jun
    Guo, Ling
    Chen, Ming-Yuan
    TUMOR BIOLOGY, 2015, 36 (10) : 7775 - 7787
12345